logo
Trump diagnosis is rare acknowledgement of president's health concerns

Trump diagnosis is rare acknowledgement of president's health concerns

Washington Post17-07-2025
The White House on Thursday said that President Donald Trump has been diagnosed with a mild but chronic illness related to his age — a rare admission from one of the nation's oldest presidents who has long sought to project vigor.
Trump has chronic venous insufficiency, the White House physician said in a memorandum, a condition in which the legs have trouble delivering blood back to the heart.
In an afternoon press briefing, White House press secretary Karoline Leavitt described the diagnosis as 'a benign and common condition, particularly in individuals over the age of 70.'
She introduced the issue after images circulated online this week of Trump with swollen legs at the FIFA World Cup and a bruised hand caked in makeup, prompting swarms of internet users to speculate that his administration was covering up a health crisis.
Trump rose to power a second time in part by drawing contrast to the mental and physical health of his predecessor, former president Joe Biden, and accusing his administration of concealing a cognitive decline. Now 79 years old, Trump has released a series of glowing medical letters about his health, repeatedly boasted about acing a cognitive test that he said was administered to him during his first term, and gone out of his way to flex his stamina with photos of golf outings and long, rousing speeches to his supporters.
As he has sought to project strength, Trump during both his 2020 and 2024 campaigns frequently raised questions about Biden's stamina, routinely referring to him with nicknames such as 'Sleepy Joe.' He also cast Biden as dishonest about his health — a charge embraced by his base that Trump continues to stoke while in office with investigations into what Biden's aides knew about the former president's mental acuity.
Leavitt told reporters during the press briefing that the president noticed 'mild swelling' in his lower legs and received an exam by the White House medical unit. She said the bruising on the back of his hands is 'consistent with minor-soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regiment.'
Some people are at a higher risk of developing chronic venous insufficiency (CVI) and varicose veins due to their family history, said Thomas Maldonado, medical director of the Venous Thromboembolic Center at NYU Langone Health. Pregnant people and individuals who are overweight are also at increased risk of the condition. CVI can also be caused by sitting or standing for long periods of time.
Symptoms of CVI include aching, throbbing or a feeling of fatigue in the legs, said Chelsea Dorsey, the director of the Vein Clinic at UChicago Medicine. Swelling, skin discoloration and varicose veins are other signs, she said. Chronic cases can lead to complications, and in some cases, CVI can be a sign of a more serious condition such as problems with the heart, liver or kidneys, doctors said.
Leavitt said Trump's doctor, Sean Barbabella, found no evidence of arterial disease, heart failure or other systemic illnesses. He provided the diagnosis in a memorandum sent Thursday, according to the document shared by the White House.
In April, Barbabella pronounced Trump, the oldest person to be sworn in as U.S. president, 'fully fit' to execute the duties of the presidency.
Teddy Amenabar and Richard Sima contributed to this report.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bristol Myers, Bain Capital form new company to develop immunology drugs
Bristol Myers, Bain Capital form new company to develop immunology drugs

Yahoo

time24 minutes ago

  • Yahoo

Bristol Myers, Bain Capital form new company to develop immunology drugs

(Reuters) -Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing immunology drugs, backed by Bain's $300 million financing round, the companies said on Monday. The new company will work on five experimental drugs licensed from Bristol Myers, including a late-stage lupus treatment and a mid-stage psoriasis drug that has shown promise in trials. Bristol Myers will retain nearly 20% equity in the venture and is set to receive royalties and milestone payments based on the drugs' success. The collaboration allows the drugmaker to concentrate its immunology research on treatments aimed at resetting the immune system while ensuring the continued development of promising assets, the companies said. "These assets have significant potential, and we are confident that this new company will drive their development to ensure greater impact for patients," said Julie Rozenblyum, senior vice president of business development at Bristol Myers. Daniel Lynch, a seasoned pharmaceutical executive, will take on the roles of executive chairman and interim CEO of the new company, while Bristol Myers' chief research officer Robert Plenge is set to join the board alongside Bain Capital partners. Canada Pension Plan Investment Board also participated in the financing round. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

What are your questions about lifestyle changes and cognitive decline?
What are your questions about lifestyle changes and cognitive decline?

CNN

time26 minutes ago

  • CNN

What are your questions about lifestyle changes and cognitive decline?

Food & health Chronic diseases Dementia Getting olderFacebookTweetLink Follow Healthy habits like eating a nutritious diet and getting regular exercise can protect your brain as you age. Research shows that it may even help after physical signs of cognitive problems begin. What do you want to know about how your lifestyle might affect your risk of cognitive decline, including conditions such as Alzheimer's disease? Share your questions with CNN below.

Trump Administration Continues Cushioning Medicare Drug Premiums
Trump Administration Continues Cushioning Medicare Drug Premiums

Bloomberg

time26 minutes ago

  • Bloomberg

Trump Administration Continues Cushioning Medicare Drug Premiums

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, but the Trump administration is continuing the policy, it told insurers Monday. The Biden administration overhauled the way Medicare, the US program for the elderly and disabled, pays for prescription drugs. Democrats capped the amount of money seniors would have to spend on drugs they pick up at the pharmacy and allowed the program to negotiate what it would pay for some high-cost medications.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store